Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01731353 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FungiScope - A Global Emerging Fungal Infection Registry

Study acronym: FungiScope
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 2025 to Dec 2026v7
  2. Primary completion date: Dec 2020 to Dec 2025v6 Show 5 more changesShow less
    • Primary endpoint revised
    • Study completion date: Dec 2021 to Dec 2025
    • Site contact updated
    • Collaborators revised (5)
    • Eligibility criteria shortened, about 2 words
  3. Site details revised
    • Collaborators: 4 to 5
    v5
  4. 2 versions Re-verified since Dec 19, 2013, no change to tracked fieldsv3-v4
  5. Primary endpoint revisedv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.
Trial Details
NCT Number NCT01731353
Lead Sponsor University of Cologne
Collaborators: Pfizer, Basilea Pharmaceutica, Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), F2G Biotech GmbH, Matinas Biopharma, Inc
Conditions
(from sponsor)		 Invasive Fungal Disease
Related terms Invasive Fungal Infections
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov